ELOXX PHARMACEUTICALS, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $13.90 million for the 12-month period ending 2014-06-30, per its 10-K filed 2016-10-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2016-10-13
- ELOXX PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2014 was $13.90M.
- ELOXX PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2013 was $0.00.
- ELOXX PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2012 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|
| 2014-06-30 | $13.90M 10-K · filed 2016-10-13 |
| 2013-06-30 | $0.00 10-K · filed 2014-09-29 |
| 2012-06-30 | $0.00 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |